Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications
The dosage and treatment frequency are tailored based on the individuals skin tone, pigmentation level, health status, and desired outcomes
The letter is available here and you can read more here
When shedding begins on GLP-1 therapy, I look for timing, diet, stress, and nutrient patterns before anything else
Each Epitalon vial contains 10 mg of lyophilized peptide at 99% HPLC purity, supplied as a research-use-only reference material
Purity, sterility, and accurate dosing are major unknowns